Risk factors associated with metabolic syndrome increased natriuresis

被引：0

作者：

Hernandez, Jesus D. ^{[1
,2
]}

Alfieri, Anna B. ^{[1
]}

Hoffmann, Irene S. ^{[1
]}

Ramirez, Alcira ^{[3
]}

机构：

[1] Univ Cent Venezuela, Fac Farm, Unidad Farmacol Clin, Caracas, Venezuela

[2] Univ Cent Venezuela, Fac Odontol, Catedra Bioquim, Caracas, Venezuela

[3] Hosp Univ Caracas, Caracas, Venezuela

来源：

REVISTA LATINOAMERICANA DE HIPERTENSION | 2012年 / 7卷 / 03期

关键词：

Metabolic Syndrome; Urinary sodium; Risk Factor;

D O I：

暂无

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

Objective: To establish whether an association exist between each component of Metabolic Syndrome (MS) and increased natriuresis. Methodology: We analyzed 998 subjects of 48, 8 +/- 0.35 years of age and measured: Body Mass Index (BMI), Waist Circumference (WC), Systolic Blood pressure (SBP), Diastolic (DBP), glycemia, lipid profile and urinary electrolyte excretion in 24 hours. Results: The high WC was the most frequent parameter (61,6%), natriuresis was higher in subjects with MS compared to those without SM (173 +/- 4.9 vs. 157 +/- 2.7 mEq/24 hours) (p < 0.0032), and only significantly correlated with BMI, WC, SBP and DBP (r = 0.394, 0.293, 0.183 and 0.214 respectively, p < 0.0001). Conclusion: increased natriuresis in MS subjets, seems to depend on adiposity, but not related to changes in glycemia or lipemia.

引用

页码：53 / 57

页数：5

共 23 条

[1] Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation [J].

Alberti, KGMM ;

Zimmet, P ;

Shaw, J .

DIABETIC MEDICINE, 2006, 23 (05) :469-480

[2]

Baculikova M, 2008, GEN PHYSIOL BIOPHYS, V27, P222

[3] PORTAL ADIPOSE-TISSUE AS A GENERATOR OF RISK-FACTORS FOR CARDIOVASCULAR-DISEASE AND DIABETES [J].

BJORNTORP, P .

ARTERIOSCLEROSIS, 1990, 10 (04) :493-496

[4] Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited [J].

Ceriello, A ;

Motz, E .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (05) :816-823

[5] Effects of oral monosodium (L)-glutamate on insulin secretion and glucose tolerance in healthy volunteers [J].

Chevassus, H ;

Renard, E ;

Bertrand, G ;

Mourand, I ;

Puech, R ;

Molinier, N ;

Bockaert, J ;

Petit, P ;

Bringer, J .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (06) :641-643

[6] Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP) [J].

Cook, Nancy R. ;

Cutler, Jeffrey A. ;

Obarzanek, Eva ;

Buring, Julie E. ;

Rexrode, Kathryn M. ;

Kumanyika, Shiriki K. ;

Appel, Lawrence J. ;

Whelton, Paul K. .

BMJ-BRITISH MEDICAL JOURNAL, 2007, 334 (7599) :885-888B

[7]

Enas Enas A, 2007, J Cardiometab Syndr, V2, P267, DOI 10.1111/j.1559-4564.2007.07392.x

[8] Prevalence of the Metabolic Syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study [J].

Escobedo, Jorge ;

Schargrodsky, Herman ;

Champagne, Beatriz ;

Silva, Honorio ;

Boissonnet, Carlos P. ;

Vinueza, Raul ;

Torres, Marta ;

Hernandez, Rafael ;

Wilson, Elinor .

CARDIOVASCULAR DIABETOLOGY, 2009, 8 :52

[9] Effects of lifestyle changes and metformin on salt sensitivity and nitric oxide metabolism in obese salt-sensitive Hispanics [J].

Hoffmann, I. S. ;

Alfieri, A. B. ;

Cubeddu, L. X. .

JOURNAL OF HUMAN HYPERTENSION, 2007, 21 (07) :571-578

[10] Salt and the metabolic syndrome [J].

Hoffmann, Irene S. ;

Cubeddu, Luigi X. .

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2009, 19 (02) :123-128

← 1 2 3 →